BIOMAT Database Logo BIOMAT Database Logo

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma. 2021

Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Hematology and Bone Marrow Transplantation Unit, AOUC Policlinico, Bari, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000090982 BNT162 Vaccine mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech. Abdavomeran,BNT-162A1,BNT-162B1,BNT-162B2,BNT-162C2,BNT162A1,BNT162B1,BNT162B2,BNT162C2,COVID-19 Vaccine Pfizer-BioNTech,Comirnaty,Pfizer Covid-19 Vaccine,Pidacmeran,Tozinameran,BNT 162A1,BNT 162B1,BNT 162B2,BNT 162C2,COVID 19 Vaccine Pfizer BioNTech,Covid-19 Vaccine, Pfizer,Pfizer Covid 19 Vaccine,Pfizer-BioNTech, COVID-19 Vaccine,Vaccine Pfizer-BioNTech, COVID-19,Vaccine, BNT162,Vaccine, Pfizer Covid-19
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised

Related Publications

Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma.
November 2021, JAMA network open,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
November 2021, Cancer cell,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
SARS-CoV-2 infection in fully vaccinated healthcare workers.
January 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
September 2021, JAMA,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
SARS-CoV-2 Vaccines in Patients With Multiple Myeloma.
March 2021, HemaSphere,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers.
January 2024, Viruses,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
January 2022, The Lancet. Infectious diseases,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
January 2022, The Lancet. Infectious diseases,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
Transmissibility of SARS-CoV-2 among fully vaccinated individuals.
January 2022, The Lancet. Infectious diseases,
Nicola Sgherza, and Paola Curci, and Rita Rizzi, and Immacolata Attolico, and Daniela Loconsole, and Anna Mestice, and Maria Chironna, and Pellegrino Musto
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
January 2023, Blood cancer journal,
Copied contents to your clipboard!